Kewenter J, Brevinge H, Engarås B, Haglind E, Ahrén C
Dept. of Surgery, Sahlgrenska Hospital, Göteborg, Sweden.
Scand J Gastroenterol. 1994 May;29(5):468-73. doi: 10.3109/00365529409096840.
All 68,308 inhabitants of Göteborg born between 1918 and 1931 were randomly divided into a test and a control group. The subjects in the test group were invited to perform Hemoccult II fecal occult blood testing on 3 days and to repeat the test after 16 to 24 months. In the prevalence screening 21,347 (63%) performed the test, and in the rescreening 19,991 (60%). Investigation of the 942 (4.4%) with positive tests in the prevalence screening showed 47 cancers and 129 subjects with adenomas > or = 1.0 cm. In the rescreening 5.1% had a positive test, and 34 cancers and 122 subjects with adenomas (> or = 1.0 cm) were found among those. Cancer had also been diagnosed in 19 subjects in the interval between the two screening occasions and in 15 subjects among the non-responders. Forty-four cancers had been diagnosed in the control group during the same period. Cancers detected by screening were at a less advanced stage than in the control group. It is too early to show any effect of screening on mortality from colorectal cancer.
哥德堡市所有1918年至1931年出生的68308名居民被随机分为试验组和对照组。试验组的受试者被邀请在3天内进行两次便隐血检测,并在16至24个月后重复检测。在患病率筛查中,21347人(63%)进行了检测,在复查中,19991人(60%)进行了检测。对患病率筛查中942名(4.4%)检测呈阳性的受试者进行调查,发现47例癌症患者和129例腺瘤≥1.0厘米的受试者。在复查中,5.1%的检测呈阳性,其中发现34例癌症患者和122例腺瘤(≥1.0厘米)受试者。在两次筛查期间,有19名受试者被诊断出患有癌症,在未做出回应的受试者中有15名被诊断出患有癌症。同期对照组中有44例癌症被诊断出来。筛查发现的癌症处于比对照组更早期的阶段。现在表明筛查对结直肠癌死亡率有任何影响还为时过早。